PPARG and myocardial infarction: In addition to its contribution to improved cardiac function post-MI, PPARγ likely mediated the beneficial effects of QLQX on fibrosis post-MI, because the PPARγ inhibitor blocked the effects of QLQX on cardiac fibrosis as determined by Masson-Trichrome staining (Figure 6A).